The Journal of Pain
Volume 10, Issue 1 , Pages 47-52 , January 2009

Hippocampal Metabolite Abnormalities in Fibromyalgia: Correlation With Clinical Features

Presented in part at the 2004 at the World Congress on Myofascial Pain and Fibromyalgia (Munich, Germany) and Human Brain Mapping (Budapest, Hungary).

  • Patrick B. Wood

      Affiliations

    • Departments of Family Medicine, Anesthesiology, and Psychiatry, LSU Health Sciences Center, Shreveport, Louisiana
    • Corresponding Author InformationAddress reprint requests to Dr. Patrick B. Wood, Angler Biomedical Technologies, LLC, 18401 Reed Parks Road, Jonestown, TX 78645
    • ,
  • Christina R. Ledbetter

      Affiliations

    • Department of Pharmacology, Toxicology, and Neuroscience, LSU Health Sciences Center, Shreveport, Louisiana
    • ,
  • Michael F. Glabus

      Affiliations

    • Laboratory of Biological Psychiatry, Department of Psychiatry, LSU Health Sciences Center, Shreveport, Louisiana
    • Deceased.
    • ,
  • Larry K. Broadwell

      Affiliations

    • Department of Internal Medicine, LSU Health Sciences Center, Shreveport, Louisiana
    • ,
  • James C. Patterson 2nd

      Affiliations

    • Department of Psychiatry, LSU Health Sciences Center, Shreveport, Louisiana
    • PET Imaging Center, Biomedical Research Institute of NW Louisiana, Shreveport, Louisiana

Received 6 February 2007 ,Revised 12 May 2008 ,Accepted 7 July 2008.

References 

  1. Adler GK, Geenen R. Hypothalamic-pituitary-adrenal and autonomic nervous system functioning in fibromyalgia. Rheum Dis Clin North Am. 2005;31:187–202
  2. Apkarian AV, Sosa Y, Sonty S, Levy RM, Harden RN, Parrish TB, et al. Chronic back pain is associated with decreased prefrontal and thalamic gray matter density. J Neurosci. 2004;24:10410–10415
  3. Brooks JC, Roberts N, Whitehouse G, Majeed T. Proton magnetic resonance spectroscopy and morphometry of the hippocampus in chronic fatigue syndrome. Br J Radiol. 2000;73:1206–1208
  4. Brown RE, Stevens DR, Haas HL. The physiology of brain histamine. Prog Neurobiol. 2001;63:637–672
  5. Burckhardt CS, Clark SR, Bennett RM. The fibromyalgia impact questionnaire (FIQ): Development and validation. J Rheumatol. 1991;18:728–733
  6. Chrousos GP. Stressors, stress, and neuroendocrine integration of the adaptive response (The 1997 Hans Selye Memorial Lecture). Ann N Y Acad Sci. 1998;851:311–335
  7. Clauw DJ, Crofford LJ. Chronic widespread pain and fibromyalgia: What we know, and what we need to know. Best Pract Res Clin Rheumatol. 2003;17:685–701
  8. Cohen H, Neumann L, Shore M, Amir M, Cassuto Y, Buskila D. Autonomic dysfunction in patients with fibromyalgia: Application of power spectral analysis of heart rate variability. Semin Arthritis Rheum. 2000;29:217–227
  9. Cook DB, Lange G, Ciccone DS, Liu WC, Steffener J, Natelson BH. Functional imaging of pain in patients with primary fibromyalgia. J Rheumatol. 2004;31:364–378
  10. Eichenbaum H. The hippocampus and declarative memory: Cognitive mechanisms and neural codes. Behav Brain Res. 2001;127:199–207
  11. Emad Y, Ragab Y, Zeinhom F, El-Khouly G, Abou-Zeid A, Rasker JJ. Hippocampus dysfunction may explain symptoms of fibromyalgia syndrome: A study with single-voxel magnetic resonance spectroscopy. J Rheumatol. 2008;35:1371–1377
  12. Floresco SB, Todd CL, Grace AA. Glutamatergic afferents from the hippocampus to the nucleus accumbens regulate activity of ventral tegmental area dopamine neurons. J Neurosci. 2001;21:4915–4922
  13. Gracely RH, Petzke F, Wolf JM, Clauw DJ. Functional magnetic resonance imaging evidence of augmented pain processing in fibromyalgia. Arthritis Rheum. 2002;46:1333–1343
  14. Grachev ID, Fredrickson BE, Apkarian AV. Abnormal brain chemistry in chronic back pain: An in vivo proton magnetic resonance spectroscopy study. Pain. 2000;89:7–18
  15. Haley RW, Marshall WW, McDonald GG, Daugherty MA, Petty F, Fleckenstein JL. Brain abnormalities in Gulf War syndrome: Evaluation with 1H MR spectroscopy. Radiology. 2000;215:807–817
  16. Harris RE, Clauw DJ, Scott DJ, McLean SA, Gracely RH, Zubieta JK. Decreased central μ-opioid receptor availability in fibromyalgia. J Neurosci. 2007;27:10000–10006
  17. Harris RE, Sundgren PC, Pang Y, Hsu M, Petrou M, Kim SH, et al. Dynamic levels of glutamate within the insula are associated with improvements in multiple pain domains in fibromyalgia. Arthritis Rheum. 2008;58:903–907
  18. Jain AK, Carruthers BM, van de Sande MI, Barron SR, Donaldson CCS, Dunne JV, et al. Fibromyalgia syndrome: Canadian Clinical Working Case Definition, Diagnostic and Treatment Protocols: A consensus document. J Musculoskel Pain. 2004;11:3–107
  19. Joels M. Corticosteroid actions in the hippocampus. J Neuroendocrinol. 2001;13:657–669
  20. Karst H, Joels M. Effect of chronic stress on synaptic currents in rat hippocampal dentate gyrus neurons. J Neurophysiol. 2003;89:625–633
  21. Kwiatek R, Barnden L, Tedman R, Jarrett R, Chew J, Rowe C, et al. Regional cerebral blood flow in fibromyalgia: Single-photon-emission computed tomography evidence of reduction in the pontine tegmentum and thalami. Arthritis Rheum. 2000;43:2823–2833
  22. Leavitt F, Katz RS. Distraction as a key determinant of impaired memory in patients with fibromyalgia. J Rheumatol. 2006;33:127–132
  23. Lieberman DN, Mody I. Substance P enhances NMDA channel function in hippocampal dentate gyrus granule cells. J Neurophysiol. 1998;80:113–119
  24. Lodge DJ, Grace AA. The hippocampus modulates dopamine neuron responsivity by regulating the intensity of phasic neuron activation. Neuropsychopharmacology. 2006;31:1356–1361
  25. Lopez JF, Akil H, Watson SJ. Neural circuits mediating stress. Biol Psychiatry. 1999;46:1461–1471
  26. Martinez-Lavin M, Hermosillo AG, Rosas M, Soto ME. Circadian studies of autonomic nervous balance in patients with fibromyalgia: A heart rate variability analysis. Arthritis Rheum. 1998;41:1966–1971
  27. McEwen BS. Effects of adverse experiences for brain structure and function. Biol Psychiatry. 2000;48:721–731
  28. McEwen BS. Plasticity of the hippocampus: Adaptation to chronic stress and allostatic load. Ann N Y Acad Sci. 2001;933:265–277
  29. McKenna JE, Melzack R. Blocking NMDA receptors in the hippocampal dentate gyrus with AP5 produces analgesia in the formalin pain test. Exp Neurol. 2001;72:92–99
  30. Menon PM, Nasrallah HA, Reeves RR, Ali JA. Hippocampal dysfunction in Gulf War Syndrome: A proton MR spectroscopy study. Brain Res. 2004;1009:189–194
  31. Mountz JM, Bradley LA, Modell JG, Alexander RW, Triana-Alexander M, Aaron LA, et al. Fibromyalgia in women: Abnormalities of regional cerebral blood flow in the thalamus and the caudate nucleus are associated with low pain threshold levels. Arthritis Rheum. 1995;38:926–938
  32. Petrou M, Harris RE, Foerster BR, McLean SA, Sen A, Clauw DJ, et al. Proton MR Spectroscopy in the evaluation of cerebral metabolism in patients with fibromyalgia: Comparison with healthy controls and correlation with symptom severity. AJNR Am J Neuroradiol. 2008;29:913–918
  33. Ploghaus A, Narain C, Beckmann CF, Clare S, Bantick S, Wise R, et al. Exacerbation of pain by anxiety is associated with activity in a hippocampal network. J Neurosci. 2001;21:9896–9903
  34. Reul JM, Sutanto W, van Eekelen JA, Rothuizen J, de Kloet ER. Central action of adrenal steroids during stress and adaptation. Adv Exp Med Biol. 1990;274:243–256
  35. Robertson DM, van Amelsvoort T, Daly E, Simmons A, Whitehead M, Morris RG, et al. Effects of estrogen replacement therapy on human brain aging: An in vivo 1H MRS study. Neurology. 2001;57:2114–2117
  36. Ross B, Bluml S. Magnetic resonance spectroscopy of the human brain. Anat Rec. 2001;265:54–84
  37. Sapolsky RM, Uno H, Rebert CS, Finch CE. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J Neurosci. 1990;10:2897–2902
  38. Schuff N, Marmar CR, Weiss DS, Neylan TC, Schoenfeld F, Fein G, et al. Reduced hippocampal volume and n-acetyl aspartate in posttraumatic stress disorder. Ann N Y Acad Sci. 1997;821:516–520
  39. Schuff N, Neylan TC, Lenoci MA, Du AT, Weiss DS, Marmar CR, et al. Decreased hippocampal N-acetylaspartate in the absence of atrophy in posttraumatic stress disorder. Biol Psychiatry. 2001;50:952–959
  40. Sheehan DV, Lecrubier Y, Sheehan KH, Amorim P, Janavs J, Weiller E, et al. The Mini-International Neuropsychiatric Interview (M.I.N.I.): The development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. J Clin Psychiatry. 1998;59(Suppl 20):22–33
  41. Stanton PK, Mody I, Heinemann U. A role for N-methyl-D-aspartate receptors in norepinephrine-induced long-lasting potentiation in the dentate gyrus. Exp Brain Res. 1989;77:517–530
  42. Wang HL, Wayner MJ, Chai CY, Lee EH. Corticotrophin-releasing factor produces a long-lasting enhancement of synaptic efficacy in the hippocampus. Eur J Neurosci. 1998;10:3428–3437
  43. Wik G, Fischer H, Bragee B, Kristianson M, Fredrikson M. Retrosplenial cortical activation in the fibromyalgia syndrome. Neuroreport. 2003;14:619–621
  44. Wolfe F, Smythe HA, Yunus MB, Bennett RM, Bombardier C, Goldenberg DL, et al. The American College of Rheumatology 1990 Criteria for the Classification of Fibromyalgia: Report of the Multicenter Criteria Committee. Arthritis Rheum. 1990;33:160–172
  45. Wood PB. Fibromyalgia: A central role for the hippocampus, a theoretical construct. J Musculoskel Pain. 2004;12:19–26
  46. Wood PB, Patterson JC, Sunderland JJ, Tainter KH, Glabus MF, Lilien DL. Reduced presynaptic dopamine activity in fibromyalgia syndrome demonstrated with positron emission tomography: A pilot study. J Pain. 2007;8:51–58
  47. Wood PB, Schweinhardt P, Jaeger E, Dagher A, Hakyemez H, Rabiner EA, et al. Fibromyalgia patients show an abnormal dopamine response to pain. Eur J Neurosci. 2007;25:3576–3582

 Supported by the American Fibromyalgia Syndrome Association (AFSA), Inc.

PII: S1526-5900(08)00650-0

doi: 10.1016/j.jpain.2008.07.003

The Journal of Pain
Volume 10, Issue 1 , Pages 47-52 , January 2009

Article Tools

* Image Usage & Resolution